These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 15975024)

  • 21. Predictive value of primate models for AIDS.
    Haigwood NL
    AIDS Rev; 2004; 6(4):187-98. PubMed ID: 15700617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Live attenuated AIDS viruses as vaccines: promise or peril?
    Ruprecht RM
    Immunol Rev; 1999 Aug; 170():135-49. PubMed ID: 10566148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
    Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenic simian/human immunodeficiency virus SHIV(KU) inoculated into immunized macaques caused infection, but virus burdens progressively declined with time.
    Silverstein PS; Mackay GA; Mukherjee S; Li Z; Piatak M; Lifson JD; Narayan O; Kumar A
    J Virol; 2000 Nov; 74(22):10489-97. PubMed ID: 11044093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accelerating HIV vaccine development using non-human primate models.
    Rahman MA; Robert-Guroff M
    Expert Rev Vaccines; 2019 Jan; 18(1):61-73. PubMed ID: 30526159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Towards an HIV-1 vaccine: lessons from studies in macaque models.
    Hulskotte EG; Geretti AM; Osterhaus AD
    Vaccine; 1998; 16(9-10):904-15. PubMed ID: 9682336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus.
    Kumar A; Mukherjee S; Shen J; Buch S; Li Z; Adany I; Liu Z; Zhuge W; Piatak M; Lifson J; McClure H; Narayan O
    Virology; 2002 Sep; 301(2):189-205. PubMed ID: 12359422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection of monkeys vaccinated with vpr- and/or nef-defective simian immunodeficiency virus strain mac/human immunodeficiency virus type 1 chimeric viruses: a potential candidate live-attenuated human AIDS vaccine.
    Igarashi T; Ami Y; Yamamoto H; Shibata R; Kuwata T; Mukai R; Shinohara K; Komatsu T; Adachi A; Hayami M
    J Gen Virol; 1997 May; 78 ( Pt 5)():985-9. PubMed ID: 9152414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards an AIDS vaccine: the role of primate models.
    Nathanson N
    Int J STD AIDS; 1998; 9 Suppl 1():3-7. PubMed ID: 9874107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B-cell antigenic sites in the envelope proteins of primate lentiviruses and their role in vaccine development.
    Norrby E; Matthews T
    AIDS; 1993; 7 Suppl 1():S127-33. PubMed ID: 8395859
    [No Abstract]   [Full Text] [Related]  

  • 31. Nonhuman primate models for the evaluation of HIV-1 preventive vaccine strategies: model parameter considerations and consequences.
    Del Prete GQ; Lifson JD; Keele BF
    Curr Opin HIV AIDS; 2016 Nov; 11(6):546-554. PubMed ID: 27559710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Live attenuated HIV vaccines: pitfalls and prospects.
    Whitney JB; Ruprecht RM
    Curr Opin Infect Dis; 2004 Feb; 17(1):17-26. PubMed ID: 15090885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetically identical primate modelling systems for HIV vaccines.
    Kent SJ; Lewis IM
    Reprod Fertil Dev; 1998; 10(7-8):651-7. PubMed ID: 10612472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation in rhesus macaques of Tat and rev-targeted immunization as a preventive vaccine against mucosal challenge with SHIV-BX08.
    Verrier B; Le Grand R; Ataman-Onal Y; Terrat C; Guillon C; Durand PY; Hurtrel B; Aubertin AM; Sutter G; Erfle V; Girard M
    DNA Cell Biol; 2002 Sep; 21(9):653-8. PubMed ID: 12396607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macaca mulatta, fascicularis and nemestrina in AIDS vaccine development.
    Baroncelli S; Negri DR; Michelini Z; Cara A
    Expert Rev Vaccines; 2008 Nov; 7(9):1419-34. PubMed ID: 18980543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells.
    Almond N; Kent K; Cranage M; Rud E; Clarke B; Stott EJ
    Lancet; 1995 May; 345(8961):1342-4. PubMed ID: 7752758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of an AIDS vaccine using Sendai virus vectors.
    Ishii H; Matano T
    Vaccine; 2015 Nov; 33(45):6061-5. PubMed ID: 26232346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel chimeric Rev, Tat, and Nef (Retanef) antigen as a component of an SIV/HIV vaccine.
    Hel Z; Johnson JM; Tryniszewska E; Tsai WP; Harrod R; Fullen J; Tartaglia J; Franchini G
    Vaccine; 2002 Aug; 20(25-26):3171-86. PubMed ID: 12163269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Worldwide survey of AIDS vaccine challenge studies in nonhuman primates: vaccines associated with active and passive immune protection from live virus challenge.
    Warren JT; Dolatshahi M
    J Med Primatol; 1992; 21(2-3):139-86. PubMed ID: 1433265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigenic and immunogenic sites of HIV-2 glycoproteins.
    Chiodi F; Björling E; Samuelsson A; Norrby E
    Chem Immunol; 1993; 56():61-77. PubMed ID: 8452654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.